Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study

Author(s):
Kavanaugh, A.; Gladman, D.; Heijde, D. van der; Purcaru, O.; Mease, P.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2015), Vol. 74, no. 1, p. 44-51
hdl
1887/101655
doi
10.1136/annrheumdis-2014-205198